SAN MATEO, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage ...

Denifanstat Phase 3 MASH program initiated in Q4 2024; patient screening expected to start in 1H 2025 Denifanstat received ...

TVB-3567 is the Company's second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 SAN MATEO, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences ...

Greg Gutfeld sounds off in a new Variety cover story on toppling Jimmy Fallon and Jimmy Kimmel in the ratings.

Denifanstat Phase 3 MASH program initiated in Q4 2024; patient screening expected to start in 1H 2025 Denifanstat received Breakthrough Therapy designation from FDA for MASH Clearance of Investigation ...

The novel, by the Mexican writer Juan Rulfo ... led by a Spanish filmmaker named Mateo Gil, never secured enough funds to start filming. Eventually, the family agreed to sell the rights to ...

Helix, a leader in population genomics and precision health, will unveil new clinical research from the Helix Research Network TM (HRN) and its partners at the 2025 ACMG Annual Clinical Genetics ...

Baszucki Group announces collaboration with Mayo Clinic for clinical trial investigating therapeutic ketogenic diet for treatment of bipolar disorder.

SAN MATEO, Calif.--(BUSINESS WIRE)--BeiGene ... With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and ...

Research, published today in Cell, outlines how scientists at the Sainsbury Wellcome Centre (SWC) at UCL developed a novel experimental ... explained Dr Mateo Velez-Fort, Senior Research Fellow ...

The glory days of the once-dominant Baltimore Orioles franchise are a distant memory. The hapless St. Louis Browns relocated ...